This event will look into key issues surrounding Clinical Trials and GCP.  A detailed overview of the current topics encountered and considered in today’s environment as a result of government targets, counterfeit medicines, exchange of information, Phase 1 Accreditation Scheme and serious breaches.
 
Aims of the seminar:

- How the inspectorate is changing, with regards to risk based inspections as a direct result of the government targets and the Hampton and McCrory reports

- The increase in potential for counterfeit products entering clinical trials, clinical trial applications from the inspectorate view and the phase 1 accreditation scheme

- Output from the serious breaches legislation, interactions with other inspectorate groups plus more information about common findings and the responses process

Date : 23-Nov-2007 - 23-Nov-2007
Location :Caledonian Hotel, Edinburgh, UK

For more information:
http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSecondary=true&ssDocName=CON2032313&ssTargetNodeId=314